Ganirelix Gedeon Richter is a medicine used to prevent premature ovulation (early release of eggs from the ovary) in women having fertility treatment and who are having ovarian stimulation (stimulation of the ovaries so that they produce more eggs). Ganirelix Gedeon Richter contains the active substance ganirelix and is a ‘generic medicine’. This means that the medicine contains the same active substance and works in the same way as a ‘reference medicine’ already authorised in the EU called Orgalutran. For more information on generic medicines, see the question-and-answer document [here](/en/documents/medicine-qa/questions-answers-generic-medicines_en.pdf).
Therapeutic Indication
### Therapeutic indication Prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).
Therapeutic Area (MeSH)
N/AATC Code
H01CC01
ATC Item
ganirelix
Pharmacotherapeutic Group
Pituitary and hypothalamic hormones and analogues
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| ganirelix acetate | N/A | 加尼瑞克 |
EMA Name
Ganirelix Gedeon Richter
Medicine Name
Ganirelix Gedeon Richter
Aliases
N/ANo risk management plan link.